Sheba Medical Center: Depressive Disorder, Major trials
The registry lists 11 Depressive Disorder, Major studies with Sheba Medical Center as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 3 1Phase 4 3No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Mitochondrial Function After KetamineNot yet recruitingNCT07399756
- Ketamine IV Classic Protocol : Five Years Follow upCompletedNCT04824157
- Ketamine Infusions for Major Depression DisorderStatus unknownNCT02219867Not applicable
- Efficacy Study of Escitalopram for Depression in Patients With DiabetesStatus unknownNCT00650897Phase 4
- Escitalopram and Sleep Architecture in Patients With Major Depressive DisorderStatus unknownNCT00442481Phase 4
- Hormonal Levels in Men With Major Depressive DisorderWithdrawnNCT00429689
- A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.Status unknownNCT00335205Phase 4
- The Effectiveness of Idazoxan in Treating TRDWithdrawnNCT00294944Phase 3
- Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression DisorderCompletedNCT00229398
- Fibromyalgia in Men Suffering From PTSDCompletedNCT00229294
- A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant DepressionStatus unknownNCT00220480Not applicable